Bacteriocin-producing oral streptococci and inhibition of respiratory pathogens.
about
Complementary and Alternative Medicine Treatment Options for Otitis Media: A Systematic ReviewProtecting against pneumococcal disease: critical interactions between probiotics and the airway microbiome.Anti-inflammatory properties of Streptococcus salivarius, a commensal bacterium of the oral cavity and digestive tract.Current concepts in host-microbe interaction leading to pneumococcal pneumoniaDo children's upper respiratory tract infections benefit from probiotics?Diversity and dynamics of bacteriocins from human microbiome.Bacterial munch for infants: potential pediatric therapeutic interventions of probiotics.Microbiome of the paranasal sinuses: Update and literature review.High Frequency and Diversity of Antimicrobial Activities Produced by Nasal Staphylococcus Strains against Bacterial CompetitorsInvestigation of Streptococcus salivarius-mediated inhibition of pneumococcal adherence to pharyngeal epithelial cellsProtective mechanisms of respiratory tract Streptococci against Streptococcus pyogenes biofilm formation and epithelial cell infection.Influence of bacterial interactions on pneumococcal colonization of the nasopharynx.Rapidly fatal hemorrhagic pneumonia and group A Streptococcus serotype M1.The microbiome of the soft palate of swine.Developing oral probiotics from Streptococcus salivarius.Otitis media among high-risk populations: can probiotics inhibit Streptococcus pneumoniae colonisation and the risk of disease?Medical prevention of recurrent acute otitis media: an updated overview.Impact of nasopharyngeal microbiota on the development of respiratory tract diseases.Probiotic bacteria inhibit the bovine respiratory pathogen Mannheimia haemolytica serotype 1 in vitro.Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a nasal spray for preventing recurrent acute otitis media in children: a real-life clinical experience.Colonization, safety, and tolerability study of the Streptococcus salivarius 24SMBc nasal spray for its application in upper respiratory tract infections.Progress in pediatrics in 2015: choices in allergy, endocrinology, gastroenterology, genetics, haematology, infectious diseases, neonatology, nephrology, neurology, nutrition, oncology and pulmonology.Comment on: "Probiotics in addition to antibiotics for the treatment of acute tonsillitis: a randomized, placebo-controlled study".Purification and characterization of anti-Alicyclobacillus bacteriocin produced by Lactobacillus rhamnosus.Inter-bacterial correlations in subgingival biofilms: a large-scale survey.Characterization of bacteriocin bificin C6165: a novel bacteriocin.Dysbiosis of oral buccal mucosa microbiota in patients with oral lichen planus.Inhibitory effect of streptococci on the growth of M. catarrhalis strains and the diversity of putative bacteriocin-like gene loci in the genomes of S. pneumoniae and its relatives.Protective Microbiota: From Localized to Long-Reaching Co-Immunity.Exploring Host-Commensal Interactions in the Respiratory Tract.Surface proteins involved in the adhesion of Streptococcus salivarius to human intestinal epithelial cells.Application of bacteriocin RC20975 in apple juice.Genomic Structural Variations Affecting Virulence During Clonal Expansion of Pseudomonas syringae pv. actinidiae Biovar 3 in Europe.Human-origin probiotic cocktail increases short-chain fatty acid production via modulation of mice and human gut microbiome
P2860
Q26766291-3ABED4F0-BC2D-4016-B446-C04048C2D115Q34299362-3439691D-4634-422E-8AFC-200F114F64D9Q34387493-BECD7BEE-A90A-4C97-B54A-2F9F70E9F511Q34540722-73643E94-93D1-4926-BC06-9294D28C0264Q35144617-40407E33-DC71-48CA-8AC0-FB36F15686A7Q35366647-259A28F3-F3AD-4277-9743-67C41E359386Q35826771-C6EBA01E-65BC-4CB1-B75C-523FFD1C691EQ35921105-390843EC-DCB0-4AD3-B20C-420D56F17661Q36094954-093A4CCE-8CC4-4EC9-8288-76BD8A88A7F6Q36146974-9F2F6DF9-D1D1-4390-9413-66C12CE36B61Q36599153-40760F55-FED9-42DE-A329-43C9E0FE8F01Q37058954-E1376E97-4C16-4194-BE05-070F47A9DB33Q37448996-4F1EDA63-F83F-4B7E-BE9F-9EBAACA2CF4AQ38031316-8BDF9B38-E951-4632-A1C9-5742AC87E7E3Q38066574-F0207F22-DB2B-4143-B7E1-0E70DD5E238AQ38091357-16AC4E6E-1CAD-454D-9BA4-4C98CEDFF7D1Q38200134-759F415E-A68D-4706-AF40-0028539934FEQ40099208-074D2AAA-CC58-42FA-A77D-E3A2CF719CA7Q40339885-8AAEC914-2178-4C70-A0FD-E0A2FD632737Q41042922-A8334CFD-C931-4D67-A1C0-54DA8793F0B8Q41092214-E3D3AB14-0686-4567-8033-5906E54D7982Q42400570-A21364FD-3DF9-40E6-9784-CB5E4252AA52Q42415370-1A62A7F6-68A7-42A9-8ADA-D94631EC881BQ43471019-2BA093D9-6E08-48FC-857F-A388AC86D68DQ43969293-3AB59414-34F7-478D-A374-6CB776DCC3DCQ44085741-A04729DC-C08B-4006-9F6D-73305082D542Q46417554-BEAB0812-3D2D-470C-B8E0-7EC9EE53B90EQ47093648-AFA5FA21-E816-489B-B172-770039DD49B6Q47152495-10597428-E50B-4772-A8FB-EA04BA1253A6Q47641823-9BCE5070-BDF0-474C-B9F3-627EB00F8C4FQ50016946-375CB6CD-884C-41C8-85C6-47DE9B127D3AQ51458100-7A6E2870-CDBF-4428-A816-DC8EBCB2BC1CQ52576108-20B77B18-9A40-4DE9-AF56-2EB9D7608FFDQ58714655-050A40DE-70E7-46FE-B35D-262C37D2FF43
P2860
Bacteriocin-producing oral streptococci and inhibition of respiratory pathogens.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Bacteriocin-producing oral streptococci and inhibition of respiratory pathogens.
@en
Bacteriocin-producing oral streptococci and inhibition of respiratory pathogens.
@nl
type
label
Bacteriocin-producing oral streptococci and inhibition of respiratory pathogens.
@en
Bacteriocin-producing oral streptococci and inhibition of respiratory pathogens.
@nl
prefLabel
Bacteriocin-producing oral streptococci and inhibition of respiratory pathogens.
@en
Bacteriocin-producing oral streptococci and inhibition of respiratory pathogens.
@nl
P2093
P2860
P1476
Bacteriocin-producing oral streptococci and inhibition of respiratory pathogens.
@en
P2093
Caterina Aiello
Francesco Patanè
Marina Scillato
P2860
P356
10.1111/J.1574-695X.2012.00928.X
P577
2012-02-03T00:00:00Z